Skip to main content

Abilify Global Settlement Order Released; Status to be Addressed on June 12

Abilify Global Settlement Order Released; Status to be Addressed on June 12

Abilify Global Settlement Order Released; Status to be Addressed on June 12

Introduction

U.S. District Judge M. Casey Rodgers overseeing the Abilify litigation, released a global settlement order (PDF) on May 2, which details the parameters for the mediation of all cases to take place between May 1 and September 1, 2018. This was in view of setting a framework to aid the settlement process using the bellwether approach.  

The parties have been given two weeks to define the ‘no pay’ characteristics where plaintiffs would not be eligible for compensation under the agreement, following which they will have 14 days to identify the cases that satisfy this condition within the centralized Abilify multidistrict litigation. The mediation process would initiate once these cases have been filtered out.

The next case management conference is scheduled for June 12, when the status of the global settlement process would be addressed. This news closely follows the May 1 decision when the defendants chose to settle before scheduled trial dates.

Over 800 Abilify lawsuits were centralized in October 2016, as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) in the U.S. District Court for the Northern District of Florida against Bristol-Myers Squibb and Otsuka Pharmaceuticals alleging that they failed to warn the consumers and the medical community about the gambling risks associated with Abilify.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!